Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Express Scripts
Federal Trade Commission
McKinsey
Cipla

Generated: July 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,233,112

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,233,112 protect, and when does it expire?

Patent 9,233,112 protects SUPRAX and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 9,233,112
Title:Pharmaceutical compositions of cefixime
Abstract: A pharmaceutical suspension dosage form comprising greater than 80 mg/ml and not more than 150 mg/ml of Cefixime and pharmaceutically acceptable excipients.
Inventor(s): Kole; Shrenik Annasaheb (Pune, IN), Metkar; Bharat Raghunath (Pune, IN), Avachat; Makarand Krishnakumar (Pune, IN)
Assignee: LUPIN LIMITED (Mumbai, Maharashtra, IN)
Application Number:13/156,146
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 9,233,112
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Use;

Drugs Protected by US Patent 9,233,112

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lupin Ltd SUPRAX cefixime FOR SUSPENSION;ORAL 202091-001 Feb 20, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHODS FOR TREATING BACTERIAL INFECTIONS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,233,112

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India330/KOL/2006Apr 13, 2006

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
AstraZeneca
Julphar
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.